Related references
Note: Only part of the references are listed.Pharmacokinetic Evaluation of Brain Penetrating Morpholine-3-hydroxy-2-pyridine Oxime as an Antidote for Nerve Agent Poisoning
Tamara Zorbaz et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Catalytic Detoxification of Organophosphorus Nerve Agents by Butyrylcholinesterase-Polymer-Oxime Bioscavengers
Libin Zhang et al.
BIOMACROMOLECULES (2020)
A protein nanocomposite for ultra-fast, efficient and non-irritating skin decontamination of nerve agents
Jiapeng Wang et al.
NANOSCALE (2020)
Novel Clinical Toxicology and Pharmacology of Organophosphorus Insecticide Self-Poisoning
Michael Eddleston
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 59 (2019)
A novel Granzyme B nanoparticle delivery system simulates immune cell functions for suppression of solid tumors
Xiaomin Qian et al.
THERANOSTICS (2019)
Modification of Lipase with Poly(4-acryloylmorpholine) Enhances Solubility and Transesterification Activity in Anhydrous Ionic Liquids
Garrett R. Chado et al.
BIOMACROMOLECULES (2018)
Potent 3-Hydroxy-2-Pyridine Aldoxime Reactivators of Organophosphate-Inhibited Cholinesterases with Predicted Blood-Brain Barrier Penetration
Tamara Zorbaz et al.
CHEMISTRY-A EUROPEAN JOURNAL (2018)
Nanocapsules of oxalate oxidase for hyperoxaluria treatment
Ming Zhao et al.
NANO RESEARCH (2018)
Impact of Polymer Bioconjugation on Protein Stability and Activity Investigated with Discrete Conjugates: Alternatives to PEGylation
Josefine Morgenstern et al.
BIOMACROMOLECULES (2018)
Why is Aged Acetylcholinesterase So Difficult to Reactivate?
Daniel M. Quinn et al.
MOLECULES (2017)
Novel brain-penetrating oximes for reactivation of cholinesterase inhibited by sarin and VX surrogates
Janice E. Chambers et al.
COUNTERMEASURES AGAINST CHEMICAL THREATS (2016)
Efficacy of novel phenoxyalkyl pyridinium oximes as brain-penetrating reactivators of cholinesterase inhibited by surrogates of sarin and VX
Janice E. Chambers et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2016)
Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation
Peng Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Reactivation of nerve agent-inhibited human acetylcholinesterase by obidoxime, HI-6 and obidoxime+HI-6: Kinetic in vitro study with simulated nerve agent toxicokinetics and oxime pharmacokinetics
Franz Worek et al.
TOXICOLOGY (2016)
Detoxification of Organophosphate Poisoning Using Nanoparticle Bioscavengers
Zhiqing Pang et al.
ACS NANO (2015)
Midazolam as an anticonvulsant antidote for organophosphate intoxicationA pharmacotherapeutic appraisal
Sandesh D. Reddy et al.
EPILEPSIA (2015)
The effect of polymer backbone chemistry on the induction of the accelerated blood clearance in polymer modified liposomes
Paul H. Kierstead et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Beneficial effects of a ketamine/atropine combination in soman-poisoned rats under a neutral thermal environment
Laure Barbier et al.
NEUROTOXICOLOGY (2015)
Developments in alternative treatments for organophosphate poisoning
Rupa Iyer et al.
TOXICOLOGY LETTERS (2015)
Relationships between the antidotal efficacy and structure, PK/PD parameters and bio-relevant molecular descriptors of AChE reactivating oximes: inclusion and integration to biopharmaceutical classification systems
Victor Voicu et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2015)
THE EFFICACY OF OXIMES IN ACUTE ORGANOPHOSPHORUS POISONING; AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS
H. Mirfazaelian et al.
VALUE IN HEALTH (2014)
Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients
Michael S. Hershfield et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic gout
Peter E. Lipsky et al.
ARTHRITIS RESEARCH & THERAPY (2014)
Biocatalytic carbon nanotube paper: a 'one-pot' route for fabrication of enzyme-immobilized membranes for organophosphate bioremediation
Guy Mechrez et al.
JOURNAL OF MATERIALS CHEMISTRY B (2014)
Progress in the development of enzyme-based nerve agent bioscavengers
Florian Nachon et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2013)
The value of novel oximes for treatment of poisoning by organophosphorus compounds
Franz Worek et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Minimal Self Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles
Pia L. Rodriguez et al.
SCIENCE (2013)
Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment
Carl D. Walkey et al.
CHEMICAL SOCIETY REVIEWS (2012)
Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents
Ricardo P. Garay et al.
EXPERT OPINION ON DRUG DELIVERY (2012)
Nanoparticle Size and Surface Chemistry Determine Serum Protein Adsorption and Macrophage Uptake
Carl D. Walkey et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2012)
FDA-approved poly(ethylene glycol)-protein conjugate drugs
Steevens N. S. Alconcel et al.
POLYMER CHEMISTRY (2011)
Evasion of the Accelerated Blood Clearance Phenomenon by Coating of Nanoparticles with Various Hydrophilic Polymers
Tsutomu Ishihara et al.
BIOMACROMOLECULES (2010)
Normal range of human red blood cell acetylcholinesterase activity
Daniel E. Arrieta et al.
DRUG AND CHEMICAL TOXICOLOGY (2009)
Antibody against poly(ethylene glycol) adversely affects PEG-asparaginase therapy in acute lymphoblastic leukemia patients
Jonathan K. Armstrong et al.
CANCER (2007)
Current understanding of the application of pyridinium oximes as cholinesterase reactivators in treatment of organophosphate poisoning
Milan Jokanovic et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Antibodies neutralizing peginterferon alfa during retreatment of hepatitis C
AA van der Eijk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
The human plasma proteome - A nonredundant list developed by combination of four separate sources
NL Anderson et al.
MOLECULAR & CELLULAR PROTEOMICS (2004)
Surface grafting of artificial joints with a biocompatible polymer for preventing periprosthetic osteolysis
T Moro et al.
NATURE MATERIALS (2004)
Effect of pegylation on pharmaceuticals
JM Harris et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Pharmacokinetics and immunologic consequences of exposing macaques to purified homologous butyrylcholinesterase
Y Rosenberg et al.
LIFE SCIENCES (2002)
Characterization of equine butyrylcholinesterase disposition in the mouse
L Koetzner et al.
DRUG METABOLISM AND DISPOSITION (2002)
Thermal degradation of poly(ethylene oxide-propylene oxide-ethylene oxide) triblock copolymer: comparative study by SEC/NMR, SEC/MALDI-TOF-MS and SPME/GC-MS
G Gallet et al.
POLYMER (2002)
Catalytic oxidative deformylation of polyethylene glycols with the participation of molecular oxygen
AM Sakharov et al.
KINETICS AND CATALYSIS (2001)
Kinetic and thermodynamic control of protein adsorption
J Satulovsky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
